This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Trazodone Hydrochloride

Read time: 1 mins
Marketing start date: 23 Dec 2024
...
 

Summary of product characteristics


Effective Time

20221031

Version

5

Spl Product Data Elements

Trazodone Hydrochloride Trazodone Hydrochloride TRAZODONE HYDROCHLORIDE TRAZODONE SILICON DIOXIDE MAGNESIUM STEARATE CELLULOSE, MICROCRYSTALLINE STARCH, CORN SODIUM LAURYL SULFATE SODIUM STARCH GLYCOLATE TYPE A POTATO WHITE TO OFF-WHITE ROUND 8;05 Trazodone Hydrochloride Trazodone Hydrochloride TRAZODONE HYDROCHLORIDE TRAZODONE SILICON DIOXIDE MAGNESIUM STEARATE CELLULOSE, MICROCRYSTALLINE STARCH, CORN SODIUM LAURYL SULFATE SODIUM STARCH GLYCOLATE TYPE A POTATO WHITE TO OFF-WHITE ROUND 8;06 Trazodone Hydrochloride Trazodone Hydrochloride TRAZODONE HYDROCHLORIDE TRAZODONE SILICON DIOXIDE MAGNESIUM STEARATE CELLULOSE, MICROCRYSTALLINE STARCH, CORN SODIUM LAURYL SULFATE SODIUM STARCH GLYCOLATE TYPE A POTATO WHITE TO OFF-WHITE OVAL 8;07 Trazodone Hydrochloride Trazodone Hydrochloride TRAZODONE HYDROCHLORIDE TRAZODONE SILICON DIOXIDE MAGNESIUM STEARATE CELLULOSE, MICROCRYSTALLINE STARCH, CORN SODIUM LAURYL SULFATE SODIUM STARCH GLYCOLATE TYPE A POTATO WHITE TO OFF-WHITE OVAL 8;08

Application Number

ANDA205253

Brand Name

Trazodone Hydrochloride

Generic Name

Trazodone Hydrochloride

Product Ndc

70771-1131

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1128-1 Trazodone Hydrochloride Tablets USP, 50 mg 100 Tablets Rx only NDC 70771-1129-1 Trazodone Hydrochloride Tablets USP, 100 mg 100 Tablets Rx only NDC 70771-1130-1 Trazodone Hydrochloride Tablets USP, 150 mg 100 Tablets Rx only NDC 70771-1131-1 Trazodone Hydrochloride Tablets USP, 300 mg 100 Tablets Rx only Trazodone Hyadrochloride Tablets, USP Trazodone Hyadrochloride Tablets, USP Trazodone Hyadrochloride Tablets, USP Trazodone Hyadrochloride Tablets, USP

Spl Medguide

SPL MEDGUIDE

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.